Suppr超能文献

应对中国结核病/耐多药结核病的挑战:采取一致行动势在必行。

Tackling challenges of TB/MDRTB in China: concerted actions are imperative.

作者信息

Tang Shenglan

机构信息

Duke Global Health Institute, Duke University, Durham, USA ; Duke Kunshan University, Global Health Research Center, Kunshan, China.

出版信息

Infect Dis Poverty. 2015 Apr 16;4:19. doi: 10.1186/s40249-015-0050-4. eCollection 2015.

Abstract

China is the second largest TB epidemic with the most number of people infected with multi-drug resistant (MDR). Over the past decade, a large number of TB control projects have been funded by the government of China and international organizations, and epidemic in China has been effectively controlled. However TB control in China still faced many challenges. Strategies to address these challenges may include integrating the national TB control program into health insurance schemes, strengthening TB case management through involving the Chinese hospital in national TB control program, and reforming payment methods for TB care as part of health system reform in China.

摘要

中国是结核病疫情第二严重的国家,耐多药感染者数量最多。在过去十年里,中国政府和国际组织资助了大量结核病控制项目,中国的疫情得到了有效控制。然而,中国的结核病控制仍面临许多挑战。应对这些挑战的策略可能包括将国家结核病控制项目纳入医疗保险计划,通过让中国医院参与国家结核病控制项目来加强结核病病例管理,以及作为中国卫生系统改革的一部分改革结核病治疗的支付方式。

相似文献

7
Prevalence of drug resistant Mycobacterium tuberculosis among children in China.中国儿童耐多药结核分枝杆菌的流行情况。
Tuberculosis (Edinb). 2015 May;95(3):315-20. doi: 10.1016/j.tube.2015.02.041. Epub 2015 Feb 21.

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验